- Di sistema
- This meeting aims to provide an updated overview of the current landscape of molecular testing in italy and europe, and to explore the clinical implications of key oncogenic drivers in non-small cell lung cancer (nsclc), including egfr, alk, ros1, kras, met, braf, her2, ret, ntrk and other emerging alterations.